Skip to main content

Polycythemia Vera clinical trials at UCSF

1 research study open to eligible people

Showing trials for
  • Rusfertide in Patients With Polycythemia Vera

    open to eligible people ages 18 years and up

    The study is designed to evaluate the safety and efficacy of rusfertide in subjects with polycythemia vera (PV) in maintaining hematocrit control and in improving symptoms of PV.

    San Francisco, California and other locations

Last updated: